Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Epithelial Pleural Mesothelioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02519049
What this trial is testing

11C-Methionine PET/CT Imaging in Patients Affected by Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Mesothelioma, Malignant
Istituto Clinico Humanitas 30
Testing effectiveness (Phase 2)Study completedNCT00061477
What this trial is testing

Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma

Who this might be right for
Mesothelioma
Eli Lilly and Company 48
Testing effectiveness (Phase 2)Study completedNCT00227630
What this trial is testing

Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC 59
Testing effectiveness (Phase 2)Looking for participantsNCT06477419
What this trial is testing

Sacituzumab Govitecan in People With Mesothelioma

Who this might be right for
MesotheliomaMesotheliomas PleuralMesothelioma; Pleura
Memorial Sloan Kettering Cancer Center 33
Not applicableUnknownNCT06031636
What this trial is testing

Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in Patients With Advanced Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma, Advanced
Tianjin Medical University Second Hospital 15
Large-scale testing (Phase 3)Study completedNCT02784171
What this trial is testing

Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma
Canadian Cancer Trials Group 520
Testing effectiveness (Phase 2)Active Not RecruitingNCT04300244
What this trial is testing

Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma

Who this might be right for
CancerCancer, LungCancer of Lung+4 more
Åslaug Helland 118
Early research (Phase 1)Ended earlyNCT02838745
What this trial is testing

Study of Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy With Pemetrexed and Cisplatin for MPM

Who this might be right for
Mesothelioma
Baylor College of Medicine 7
Testing effectiveness (Phase 2)Study completedNCT02049060
What this trial is testing

Study of the Combination of Tivantinib Plus Pemetrexed and Carboplatin

Who this might be right for
Malignant Pleural MesotheliomaNonsquamous Nonsmall Cell Neoplasm of Lung
Armando Santoro, MD 31
Testing effectiveness (Phase 2)Study completedNCT01486368
What this trial is testing

A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
NCIC Clinical Trials Group 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT01843374
What this trial is testing

Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma

Who this might be right for
Unresectable Pleural or Peritoneal Malignant Mesothelioma
MedImmune LLC 571
Large-scale testing (Phase 3)Study completedNCT00128102
What this trial is testing

Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (MK-0683-014)

Who this might be right for
MesotheliomaLung Cancer
Merck Sharp & Dohme LLC 661
Testing effectiveness (Phase 2)Ended earlyNCT01870609
What this trial is testing

Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Verastem, Inc. 344
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Not applicableEnded earlyNCT00898547
What this trial is testing

Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107

Who this might be right for
Malignant Mesothelioma
Alliance for Clinical Trials in Oncology 47
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05425576
What this trial is testing

OT-101 in Combination With Pembrolizumab in Subjects With Malignant Pleural Mesothelioma Failing to Respond to Checkpoint Inhibition

Who this might be right for
Malignant Pleural Mesothelioma
Oncotelic Inc. 63
Testing effectiveness (Phase 2)Looking for participantsNCT06840834
What this trial is testing

Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy

Who this might be right for
Pleural Mesotheliomas
Intergroupe Francophone de Cancerologie Thoracique 38
Testing effectiveness (Phase 2)Looking for participantsNCT05960773
What this trial is testing

Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma

Who this might be right for
MesotheliomaMalignant Mesothelioma (MM)Early-stage Mesothelioma+3 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Looking for participantsNCT06057935
What this trial is testing

Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

Who this might be right for
Malignant Peritoneal MesotheliomaPeritoneal MesotheliomaMesothelioma+2 more
Memorial Sloan Kettering Cancer Center 64
Early research (Phase 1)Study completedNCT03678350
What this trial is testing

Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery

Who this might be right for
Malignant MesotheliomaNon-Small Cell Lung CarcinomaPleural Disorder
Roswell Park Cancer Institute 9
Next Page